Yasin Folkvaljon
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Work-up and treatment of prostate cancer before and after publication of the first national guidelines on prostate cancer care in Sweden.
Journal: Scandinavian journal of urology
Published: October 27, 2018
Defining Intermediate Risk Prostate Cancer Suitable for Active Surveillance.
Journal: The Journal of urology
Published: September 22, 2018
Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity.
Journal: Breast cancer research and treatment
Published: July 06, 2018
Temporal trends in incidence and outcome of hydatidiform mole: a retrospective cohort study.
Journal: Acta oncologica (Stockholm, Sweden)
Published: February 17, 2018
Nationwide population-based study on the use of novel antiandrogens in men with prostate cancer in Sweden.
Journal: Scandinavian journal of urology
Published: February 02, 2018
Prognostic scoring systems for myelodysplastic syndromes (MDS) in a population-based setting: a report from the Swedish MDS register.
Journal: British journal of haematology
Published: November 23, 2017
Survival and risk of breast cancer recurrence after breast reconstruction with deep inferior epigastric perforator flap.
Journal: The British journal of surgery
Published: November 16, 2017
Nationwide, population-based study of post radical prostatectomy urinary incontinence correction surgery.
Journal: Journal of surgical oncology
Published: August 01, 2017
Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 28, 2017
Long-term adverse effects after retropubic and robot-assisted radical prostatectomy. Nationwide, population-based study.
Journal: Journal of surgical oncology
Published: April 11, 2017
Meta-Analysis of the Association Between Phosphodiesterase Inhibitors (PDE5Is) and Risk of Melanoma.
Meta-Analysis of the Association Between Phosphodiesterase Inhibitors (PDE5Is) and Risk of Melanoma.
Journal: Journal of the National Cancer Institute
Published: December 27, 2016
Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden.
Journal: JAMA oncology
Published: October 22, 2016
Last Updated: 09/26/2026